Immune-Mediated Coagulopathy in COVID-19 Infection

Zahava Vadasz^{1

2}, Benjamin Brenner^{2

3

4}, Elias Toubi^{1

2}

Affiliations

¹ Proteomic and Clinical Flow Cytometry Unit, Bnai-Zion Medical Center, Haifa, Israel.
² Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.
³ Department of Hematology, Rambam Health Care Campus, Haifa, Israel.
⁴ Department of Obstetrics and Gynaecology, I.M. Sechenov First Moscow State Medical University, Moscow, Russia.

Review

Zahava Vadasz et al. Semin Thromb Hemost. 2020 Oct.

. 2020 Oct;46(7):838-840.

doi: 10.1055/s-0040-1714272. Epub 2020 Sep 2.

Zahava Vadasz^{1

2}, Benjamin Brenner^{2

3

4}, Elias Toubi^{1

2}

¹ Proteomic and Clinical Flow Cytometry Unit, Bnai-Zion Medical Center, Haifa, Israel.
² Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.
³ Department of Hematology, Rambam Health Care Campus, Haifa, Israel.
⁴ Department of Obstetrics and Gynaecology, I.M. Sechenov First Moscow State Medical University, Moscow, Russia.

No abstract available

Conflict of interest statement

Dr. Brenner reports personal fees from Pfizer, LEO Pharma, Sanofi, ROVI Laboratories, and Bayer Pharmaceuticals, outside the submitted work.

1. Toubi E, Vadasz Z. Innate immune-responses and their role in driving autoimmunity. Autoimmun Rev. 2019;18(03):306–311. - PubMed
1. Henderson L A, Canna S W, Schulert G S.On the alert for cytokine storm: immunopathology in COVID-19 Arthritis Rheumatol 2020(e-pub ahead of print)10.1002/art.41285 - DOI - PMC - PubMed
1. Llitjos J F, Leclerc M, Chochois C.High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients J Thromb Haemost 2020(e-pub ahead of print)10.1111/jth.14869 - DOI - PMC - PubMed
1. Cao W, Li T. COVID-19: towards understanding of pathogenesis. Cell Res. 2020;30(05):367–369. - PMC - PubMed
1. Chen G, Wu D, Guo W. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130(05):2620–2629. - PMC - PubMed